CITECH in Restructuring Phase with Subsidiary Sale and Merger, Operating Loss Continues

Sold entire stake in subsidiary Anrobotics (formerly Naicom) on Jan 9, 2026 (gain of KRW 8.6bn)
Absorbed subsidiary Cevic on April 1, 2026 (zero-stock merger for business diversification and efficiency)
Consolidated Q1 2026 revenue: KRW 65.9bn (down from KRW 133.9bn in same period last year, affected by discontinued operations)
Consolidated operating loss: KRW 1.5bn (vs. operating profit of KRW 2.0bn in full year 2025)
Consolidated net income: KRW 6.9bn (including one-time disposal gain of KRW 8.6bn and financial asset valuation gain of KRW 1.2bn)
Net debt: KRW 11.0bn, capital gearing ratio: 13.9% (improved from 17.3% at year-end)
Cash & equivalents: KRW 9.7bn (up from KRW 7.4bn at year-end)
New business initiatives: AI healthcare platform, smart hospital solutions, PA (public address) business
New stock options granted (9th: 740,000 shares, 10th: 120,000 shares)